Solriktug Study for Adults with Asthma

This study aims to test a new medication called solriktug for adults with asthma. Asthma is a condition where your airways swell and make it hard to breathe. The study will last 12 weeks, during which participants will receive either solriktug or a placebo (a harmless pill that does not contain medicine) through injections under the skin. The study will also have a 16-week follow-up period to check on participants' health. Around 140 adults will take part in this study.

• Participants must be 18 to 75 years old and have had asthma for at least one year.
• Participants will receive injections at the study site and continue their regular asthma medication.
• People who smoke or have certain health issues cannot join the study.

Joining the study means regular visits to the study site for injections and check-ups. The study will help researchers understand if solriktug is safe and effective for treating asthma in adults.